• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Vivaglobin

Proper Name: Immune Globulin Subcutaneous (Human)
Tradename: Vivaglobin
Manufacturer: CSL Behring GmbH, License #1765

Package Insert (PDF - 152 KB) - Approved: January 9, 2006


Date: January 9, 2006
Indication: Treatment of patients with primary immune deficiency (PID)
January 9, 2006 Approval Letter
Press Release: FDA Approves First Immune Globulin for Subcutaneous Use - January 9, 2006
Summary Basis of Approval (PDF-186 KB) - January, 2006